Zimmer Biomet logo
Zimmer Biomet
ZBH | NYSE
Chart Builder DCF Calculator
$101.41
-$1.80 (-1.74%)
At close: Nov 16, 2026, 4:00 PM ET
$101.41
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:35 PM ET

Zimmer Biomet Company Profile

Company profile explained

Company Profile

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Key Executives

Name Position
Ivan Tornos President, Chief Executive Officer & Chairman of the Board
Angela Main Senior Vice President, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific
Chad F. Phipps Senior VP, Chief Legal & Corporate Affairs Officer and Secretary
David DeMartino Senior Vice President of Investor Relations
JehanZeb Noor Senior VP, Chief Strategy, Business Development, Innovation & Transformation Officer
Jonathan Vigdorchik Chief Science, Technology & Medical Affairs Officer
Kevin R. Thornal Group President of Global Businesses & Americas
Kristen Cardillo Senior Vice President & Chief Communications Officer
Paul A. Stellato Interim CFO, VP, Controller & Chief Accounting Officer
Shaun Braun Senior Vice President & Chief Information and Technology Officer
Wilfred van Zuilen Group President of Europe, Middle East & Africa

Latest SEC Filings

Date Type Title
Oct 05, 2026 4 Filing
Oct 05, 2026 3 Filing
Oct 05, 2026 3 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
View All SEC Filings ➞
Zimmer Biomet
Zimmer Biomet logo
Country United States
IPO Date Jul 25, 2001
Industry Medical - Devices
Sector Healthcare
Employees 17,000
CEO Ivan Tornos

Contact Details

345 East Main Street Warsaw, Indiana 46580 United States

Stock Details

Ticker Symbol ZBH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001136869
CUSIP Number 98956P102
ISIN Number US98956P1021
SIC Code 3842

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.